Abstract:Open AccessMoreSectionsView PDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InRedditEmail Cite this article Wang Feng, Zhang Weihua, Wu Tianfeng and Chu Heying 2020Retraction: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progressionOpen Biol.10200204200204http://doi.org/10.1098/rsob.200204SectionOpen AccessRetractionRetraction: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression Feng Wang Feng Wang Google Scholar Find this author on PubMed Search for more papers by this author , Weihua Zhang Weihua Zhang Google Scholar Find this author on PubMed Search for more papers by this author , Tianfeng Wu Tianfeng Wu Google Scholar Find this author on PubMed Search for more papers by this author and Heying Chu Heying Chu Google Scholar Find this author on PubMed Search for more papers by this author Feng Wang Feng Wang Google Scholar Find this author on PubMed , Weihua Zhang Weihua Zhang Google Scholar Find this author on PubMed , Tianfeng Wu Tianfeng Wu Google Scholar Find this author on PubMed and Heying Chu Heying Chu Google Scholar Find this author on PubMed Published:22 July 2020https://doi.org/10.1098/rsob.200204This article retracts the followingResearch ArticleRETRACTED: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progressionhttps://doi.org/10.1098/rsob.180132 Feng Wang, Weihua Zhang, Tianfeng Wu and Heying Chu volume 8issue 10Open Biology31 October 2018 Open Biol. 8, 180132. (Published 31 October 2018). (doi:10.1098/rsob.180132) The Editor-in-Chief in agreement with the Publisher has retracted this article. Following an investigation, we have found that the published manuscript has substantial overlap with a previously published manuscript [1] in the text and figures (notably figure 1 Kaplan–Meier curves, table values, line graphs and figure 3 western blots). This paper has been identified among of a set of papers that present significant text and data duplication and therefore the data reported in this article are unreliable. The authors are in agreement with this retraction. Corresponding authors Yu Zhouxu ([email protected]) Feng Wang ([email protected]) Prof. Jon Pines FRS Editor-in-Chief, Open Biology Footnotes © 2020 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.ReferencesReference1. Yan X, Zhao J, Zhang R. 2017 Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression. Oncotarget 8, 49 064-49 075. (doi:10.18632/oncotarget.17093) Crossref, Google Scholar Previous Article VIEW FULL TEXT DOWNLOAD PDF FiguresRelatedReferencesDetailsRelated articlesRETRACTED: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression31 October 2018Open Biology This Issue July 2020Volume 10Issue 7 Article InformationDOI:https://doi.org/10.1098/rsob.200204PubMed:32692958Published by:Royal SocietyOnline ISSN:2046-2441History: Published online22/07/2020 License:© 2020 The Authors.Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited. Citations and impact Subjects biochemistry

Retraction: WSB2 as a target of Hedgehog signaling promoted the malignantbiological behavior of Xuanwei lung cancer through regulating Wnt/β-catenin signaling

RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] SRC‐like adaptor protein negatively regulates Wnt signaling in intrahepatic cholangiocarcinoma

RETRACTED: KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the β-catenin/STT3 signaling pathway

[Retracted] Effect of RhoC on the epithelial‐mesenchymal transition process induced by TGF‐β1 in lung adenocarcinoma cells

Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781–790.

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling

RETRACTED: Protective Autophagy Induced by Physcion Suppresses Hepatocellular Carcinoma Cell Metastasis by Inactivating the JAK2/STAT3 Axis.

Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F‐box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin‐mediated degradation of Snail. FEBS Open Bio, 10: 1810–1820.

RETRACTION: The Novel Role of Circular RNA ST3GAL6 on Blocking Gastric Cancer Malignant Behaviours Through Autophagy Regulated by the FOXP2/MET/Mtor Axis

Retracted: Fbxw7 and Skp2 Regulate Stem Cell Switch between Quiescence and Mitotic Division in Lung Adenocarcinoma

[Retracted] Tripartite motif‐containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway

Retraction: Reduced Interleukin-38 in Non-Small Cell Lung Cancer is Associated with Tumour Progression

[Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‐1 degradation via the ubiquitin‐proteasome pathway

[Retracted] Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high‐throughput sequencing

RETRACTED ARTICLE: Long Non-Coding RNA 91H Regulates IGF2 Expression by Interacting with IGF2BP2 and Promotes Tumorigenesis in Colorectal Cancer

RETRACTION: miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer (Retraction of Vol 234, Pg 23596, 2020)

Retraction: 'ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer'. Zhen-Ya Gao, Fang Yu, Huan-Xia Jia, Zhuo Ye, Shi-Jie Yao, Kaohsiung J Med Sci. 2020; 36: 1021-1029 (https://doi.org/10.1002/kjm2.12284)